NanoViricides
NNVC
#10585
Rank
A$47.48 M
Marketcap
A$1.86
Share price
-0.76%
Change (1 day)
-15.77%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): A-$0.67

According to NanoViricides's latest financial reports the company's current EPS (TTM) is A-$0.63. In 2025 the company made an earnings per share (EPS) of A-$0.90 an increase over its 2024 EPS that were of A-$1.00.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.67-25.71%
2025A-$0.90-10%
2024A-$1.00-5.41%
2023A-$1.065.71%
2022A-$1.00-13.58%
2021A-$1.16-66.11%
2020A-$3.421.7%
2019A-$3.36-10.98%
2018A-$3.78-22.35%
2017A-$4.87-10.53%
2016A-$5.44375%
2015A-$1.14-85.19%
2014A-$7.7342.11%
2013A-$5.4426.67%
2012A-$4.29-6.25%
2011A-$4.5814.28%
2010A-$4.01100%
2009A-$2.00-0%
2008A-$2.00-33.33%
2007A-$3.01-0%
2006A-$3.014445.07%
2005A-$0.06612

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
A-$3.72 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.81-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.50-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.58-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A-$2.18 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$2.06 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA